Galux

Seoul, South Korea · Founded 2020 · Privately Held (backing)

Developer of molecular design technology designed to develop novel drugs against attractive targets. Galux is based in Seoul, South Korea and was founded in 2020. Its last reported valuation was $67.8 million in Oct 2022. It has raised $32.4 million.

Last reported valuation
$67.8M
Oct 2026
Priced at
—
Total raised
$32.4M
Last round
—

Who backs Galux?

20 investors
InvestorType
Korea Development BankOther
InterVestVenture capital
KDB CapitalOther
DAYLI PartnersVenture capital
NH Investment & SecuritiesOther
Korea Investment & SecuritiesOther
Yuanta InvestmentVenture capital
TKG VenturesVenture capital
NCORE VenturesVenture capital
Pathway Capital ManagementFund of funds
+ 10 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Galux investors

20 investors are on record for Galux, including Korea Development Bank, InterVest, KDB Capital and DAYLI Partners. By type, the record holds 5 venture capital firms and 1 fund of funds.

Free account
More of Galux with a free account
  • ·The complete investor list: 20 names
  • ·Watch Galux: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 20 firms already write checks for companies like Galux. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View